Cargando…
Characterizing the Retinal Phenotype of the Thy1-h[A30P]α-syn Mouse Model of Parkinson’s Disease
Despite decades of research, disease-modifying treatments of Parkinson’s disease (PD), the second most common neurodegenerative disease worldwide, remain out of reach. One of the reasons for this treatment gap is the incomplete understanding of how misfolded alpha-synuclein (α-syn) contributes to PD...
Autores principales: | Veys, Lien, Devroye, Joyce, Lefevere, Evy, Cools, Lien, Vandenabeele, Marjan, De Groef, Lies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452874/ https://www.ncbi.nlm.nih.gov/pubmed/34557068 http://dx.doi.org/10.3389/fnins.2021.726476 |
Ejemplares similares
-
A novel retinal ganglion cell quantification tool based on deep learning
por: Masin, Luca, et al.
Publicado: (2021) -
MMP2 Modulates Inflammatory Response during Axonal Regeneration in the Murine Visual System
por: Andries, Lien, et al.
Publicado: (2021) -
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment
por: Van Hove, Inge, et al.
Publicado: (2016) -
A Mouse Model to Test Novel Therapeutics for Parkinson’s Disease: an Update on the Thy1-aSyn (“line 61”) Mice
por: Richter, Franziska, et al.
Publicado: (2023) -
Electroacupuncture Modulates 5-HT(4R)-Mediated cAMP/PKA Signaling to Improve Intestinal Motility Disorders in a Thy1-αSyn Parkinson's Mouse Model
por: Shen, Lin, et al.
Publicado: (2022)